Community Pharmacists as Partners in Reducing Suicide Risk

References

1. 1.↵
   National Institute of Mental Health. Suicide. Available from: https://www.nimh.nih.gov/health/statistics/suicide.shtml. Updated May 2018. Accessed May 8, 2019.
2. 2.↵
   1. Smith RC

   . Educating trainees about common mental health problems in primary care: a (not so) modest proposal. Acad Med 2011;86:e16.

   OpenUrlPubMed
3. 3.↵
   U.S. Preventative Services Task Force. Final recommendation statement. Depression in adults: screening. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/depression-in-adults-screening1. Updated January 2016. Accessed May 08, 2019.
4. 4.↵
   American Psychiatric Association. Depression screening rates in primary care remain low. Available from: https://www.psychiatry.org/newsroom/news-releases/depression-screening-rates-in-primary-care-remain-low. Published February 15, 2017. Accessed May 08, 2019.
5. 5.↵
   1. Harrison DL,
   2. Miller MJ,
   3. Schmitt MR,
   4. Touchet BK

   . Variations in the probability of depression screening at community-based physician practice visits. Prim Care Companion J Clin Psychiatry 2010;12:PCC.09m00911.
6. 6.↵
   1. LaVito A

   . Suicide rates are climbing and the CDC says mental illness isn't the only factor to blame. Available from: https://www.cnbc.com/2018/06/07/suicide-rates-are-climbing-and-mental-illness-isnt-the-only-factor.html. Published June 7, 2018. Accessed January 8, 2019.
7. 7.↵
   1. Belluz J

   . Anthony Bourdain's death is one in a growing public health tragedy. Available from: https://www.vox.com/science-and-health/2018/6/8/17441330/anthony-bourdain-suicide-rates-us-cdc. Published June 8, 2018. Accessed May 8, 2019.
8. 8.↵
   1. Case A,
   2. Deaton A

   . Mortality and morbidity in the 21^st century. Available from: https://www.brookings.edu/wp-content/uploads/2017/08/casetextsp17bpea.pdf. Published 2017. Accessed May 08, 2019.
9. 9.↵
   1. Rubin R

   . Thanks to Logic's song, the phones at ‘1–800-273–8255′ are ringing off the hook. Available from: https://variety.com/2017/music/news/1-800–273-8255-logic-song-suicide-prevention-lifeline-1202542381/. Published August 30, 2017. Accessed May 08, 2019.
10. 10.↵
    1. Luoma JB,
    2. Martin CE,
    3. Pearson JL

    . Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry 2002;159:909–16.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Moose J,
    2. Branham A

    . Pharmacists as influencers of patient adherence. Available from: https://www.pharmacytimes.com/publications/directions-in-pharmacy/2014/august2014/pharmacists-as-influencers-of-patient-adherence-. Published August 21, 2014. Accessed May 08, 2019.
12. 12.↵
    1. Kniesner TJ,
    2. Powers PH,
    3. Croghan TW

    . Provider type and depression treatment adequacy. Health Policy 2005;72:321–32.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    Mental Health America. 2017 State of mental health in America—access to care data. Available from: http://www.mentalhealthamerica.net/issues/2017-state-mental-health-america-access-care-data. Accessed May 8, 2019.
14. 14.↵
    1. Murphy AL,
    2. Martin-Misener R,
    3. Kutcher SP,
    4. O'Reilly CL,
    5. Chen TF,
    6. Gardner DM

    . From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies. BMC Health Serv Res 2016;16:569.

    OpenUrl
15. 15.↵
    1. O'Reilly CL,
    2. Wong E,
    3. Chen TF

    . A feasibility study of community pharmacists performing depression screening services. Res Social Admin Pharm 2015;11:364–81.

    OpenUrl
16. 16.↵
    1. Painter NA,
    2. Kuo GM,
    3. Collins SP,
    4. Palomino YL,
    5. Lee KC

    . Pharmacist training in suicide prevention. J Am Pharm Assoc 2018;58:199–204.

    OpenUrl
17. 17.↵
    1. Wilson C,
    2. Twigg G

    . Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population. J Am Pharm Assoc 2018;58:205–9.

    OpenUrl
18. 18.↵
    1. Rosser S,
    2. Frede S,
    3. Conrad WF,
    4. Heaton PC

    . Development, implementation, and evaluation of a pharmacist-conducted screening program for depression. J Am Pharm Assoc 2008;48:46–51.

    OpenUrl
19. 19.↵
    1. Kerner Hare S,
    2. Kraenow K

    . Depression screenings: developing a model for use in a community pharmacy. J Am Pharm Assoc 2008;48:46–51.

    OpenUrl
20. 20.↵
    1. Knox ED,
    2. Dopheide JA,
    3. Wincor MZ,
    4. Han PK

    . Depression screening in a university campus pharmacy: a pilot project. J Am Pharm Assoc 2006;48:502–6.

    OpenUrl
21. 21.↵
    1. Caley CF,
    2. Stimmel GL

    . Characterizing the relationship between individuals with mental health conditions and community pharmacists. Available from: https://cpnpf.org/_docs/foundation/2012/nami-survey-report.pdf. Published 2012. Accessed January 8, 2019.
22. 22.↵
    1. Knox K,
    2. Fejzic J,
    3. Mey A,
    4. et al

    . Mental health consumer and caregiver perceptions of stigma in Australian community pharmacies. Int J Soc Psychiatry 2014;60:533–43.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Qato DM,
    2. Ozenberger K,
    3. Olfson M

    . Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018;319:2289–98.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Lavigne JE

    . Suicidal ideation and behavior as adverse events of prescribed medications: an update for pharmacists. J Am Pharm Assoc 2016;56:203–6.

    OpenUrl
25. 25.↵
    1. Watkins A,
    2. McKee J,
    3. Hughes C,
    4. Pfeiffenberger T

    . Community pharmacists' attitudes towards providing care and services to patients with severe and persistent mental illness. J Am Pharm Assoc 2017;57:S217–S224.

    OpenUrl
26. 26.↵
    1. Giannetti V,
    2. Caley CF,
    3. Kamal KM,
    4. et al

    . Community pharmacists and mental illness: a survey of service provisions, stigma, attitudes and beliefs. Int J Clin Pharm 2018;40:1096–105.

    OpenUrl
27. 27.↵
    1. Scheerder G,
    2. De Coster I,
    3. Van Audenhove C

    . Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv 2008;59:1155–60.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Benfield MJ,
    2. Mospan C,
    3. Gillette C,
    4. Pierce B

    . Community pharmacist attitudes, perceptions, and barriers in performing suicidal ideation assessment. Poster presentation at the 2018 North Carolina Pharmacists Association Annual Meeting, Winston-Salem, NC. North Carolina Pharmacist Journal 2018;98:33–4.

    OpenUrl
29. 29.↵
    1. Carpenter DM,
    2. Lavigne JE,
    3. Roberts CA,
    4. Zacher J,
    5. Colmenares EW

    . A review of suicide prevention programs and training policies for pharmacists. J Am Pharm Assoc 2018;58:522–9.

    OpenUrl
30. 30.↵
    1. Morgan AJ,
    2. Ross A,
    3. Reavley NJ

    . Systematic review and meta-analysis of Mental Health First Aid training: Effects on knowledge, stigma, and helping behavior. PLoS One 2018;13:e0197102.

    OpenUrl
31. 31.↵
    Mental Health First Aid Australia. MHFA research. Available from: https://mhfa.com.au/mhfa-research. Accessed May 08, 2019.
32. 32.↵
    Pharmacy Guild of Australia. Quality care pharmacy program. Canberra, Australia: Pharmacy Guild of Australia; 2014.
33. 33.↵
    1. Winchester BR,
    2. Watkins SC,
    3. Brahm NC,
    4. Harrison DL,
    5. Miller MJ

    . Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative care. Ann Pharmacother 2013;47:797–804.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Calogero S,
    2. Caley CF

    . Supporting patients with mental illness: deconstructing barriers to community pharmacist access. J Am Pharm Assoc 2017;57:248–55.

    OpenUrl
35. 35.↵
    1. Claasseen CA,
    2. Pearson JL,
    3. Khodyakov D,
    4. et al

    . Reducing the burden of suicide in the U.S.: the aspirational research goals of the National Action Alliance for Suicide Prevention Research Prioritization Task Force. Am J Prev Med 2014;47:309–14.

    OpenUrlCrossRefPubMed
36. 36.
    1. Tucker RP,
    2. Crowley KJ,
    3. Davidson CL,
    4. Gutierrez PM

    . Risk factors, warning signs, and drivers of suicide: what are they, how do they differ, and why does it matter? Suicide Life Threat Behav 2015;45:679–89.

    OpenUrl
37. 37.
    1. Raue PJ

    . Physicians are less likely to assess and manage suicide risk among older adults: broader implications for suicide prevention within primary care. Am J Geriatric Psychiatry 2019;27:609–610.

    OpenUrl
38. 38.
    1. Vannoy S,
    2. Park M,
    3. Maroney MR,
    4. Unützer J,
    5. Apesoa-Varano EC,
    6. Hinton L

    . The perspective of older men with depression on suicide and its prevention in primary care: Implications for primary care engagement strategies. Crisis 2018;39:397–405.

    OpenUrl
39. 39.
    1. Graves JM,
    2. Mackelprang JL,
    3. Van Natta SE,
    4. Holliday C

    . Suicide prevention training: policies for health care professionals across the United States as of October 2017. Am J Public Health 2018;108:760–8.

    OpenUrl
40. 40.
    1. Murphy AL,
    2. Gardner DM,
    3. Chen TF,
    4. O'Rielly C,
    5. Kutcher SP

    . Community pharmacists and the assessment and management of suicide risk. Can Pharm J (Ott) 2015;148:171–5.

    OpenUrlCrossRef